Halberd

Halberd ROE

The Return on Equity (ROE) of Halberd (HALB) as of Oct 10, 2026 is 2.20 %. In the previous year, Return on Equity (ROE) was 11.09 % — a change of -80.18% (lower).

ROE

2.20 %

YoY

-80.18%

Last updated:

In 2025, Halberd's return on equity (ROE) was 2.20 %, a -80.18% increase from the 11.09 % ROE in the previous year.

The Halberd ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2017
59.92 USD
Jan 1, 2019
4.66 USD
Jan 1, 2020
576.88 USD
Jan 1, 2021
177.51 USD
Jan 1, 2022
223.21 USD
Jan 1, 2023
49.02 USD
Jan 1, 2024
11.09 USD
Jan 1, 2025
2.20 USD
The Halberd ROE history
YEARROEYoY
2.20 %-80.18%
11.09 %-77.38%
49.02 %-78.04%
223.21 %+25.75%
177.51 %-69.23%
576.88 %+12,269.12%
4.66 %-92.22%
59.92 %-6,404.02%
-0.95 %—
Access this data via the Eulerpool API

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

ROE Details

Decoding Halberd's Return on Equity (ROE)

Halberd's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Halberd's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Halberd's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Halberd’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Halberd stock

Return on Equity (ROE) of Halberd is 2.20 % in 2025.

Return on Equity (ROE) of Halberd changed from 11.09 % to 2.20 %, representing a -80.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Halberd since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Halberd with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Halberd

All Key Metrics — Halberd